News stories about Colgate-Palmolive (NYSE:CL) have been trending somewhat positive on Wednesday, according to Accern. Accern identifies positive and negative news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Colgate-Palmolive earned a news sentiment score of 0.17 on Accern’s scale. Accern also gave headlines about the company an impact score of 47.444344341327 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
These are some of the news articles that may have impacted Accern’s scoring:
- Insider Selling: Colgate-Palmolive (CL) Insider Sells 19,500 Shares of Stock (americanbankingnews.com)
- Risk Factors under Consideration – Colgate-Palmolive Company (NYSE:CL) (thestockgem.com)
- Colgate-Palmolive Company (CL) Ex-Dividend Date Scheduled for April 19, 2018 (nasdaq.com)
- Colgate-Palmolive’s (CL) Hold Rating Reiterated at Stifel Nicolaus (americanbankingnews.com)
- Analysts’ Recommendation in Spotlight – Colgate-Palmolive Company (NYSE: CL) (alphabetastock.com)
NYSE:CL traded down $0.15 during trading hours on Wednesday, reaching $72.08. 3,840,647 shares of the company were exchanged, compared to its average volume of 3,944,426. The company has a market capitalization of $63,408.67, a P/E ratio of 25.11, a P/E/G ratio of 2.73 and a beta of 0.74. Colgate-Palmolive has a 1-year low of $67.86 and a 1-year high of $77.91. The company has a debt-to-equity ratio of 27.02, a current ratio of 1.36 and a quick ratio of 1.00.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.75. The business had revenue of $3.89 billion for the quarter, compared to the consensus estimate of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.75 earnings per share. sell-side analysts anticipate that Colgate-Palmolive will post 3.18 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 15th. Investors of record on Friday, April 20th will be given a dividend of $0.42 per share. The ex-dividend date is Thursday, April 19th. This represents a $1.68 dividend on an annualized basis and a yield of 2.33%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.40. Colgate-Palmolive’s dividend payout ratio is currently 55.75%.
Several research firms have recently commented on CL. Jefferies Group reaffirmed a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a research report on Friday, January 26th. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $75.00 target price on shares of Colgate-Palmolive in a research report on Wednesday. Barclays set a $75.00 target price on Colgate-Palmolive and gave the company a “hold” rating in a research report on Thursday, March 15th. Finally, Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price on the stock in a research report on Tuesday, December 19th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $77.91.
In other Colgate-Palmolive news, insider Daniel B. Marsili sold 19,500 shares of the firm’s stock in a transaction on Monday, April 16th. The stock was sold at an average price of $71.85, for a total value of $1,401,075.00. Following the sale, the insider now owns 77,935 shares of the company’s stock, valued at approximately $5,599,629.75. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Daniel B. Marsili sold 5,692 shares of the firm’s stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $70.19, for a total value of $399,521.48. Following the completion of the sale, the insider now directly owns 41,677 shares in the company, valued at approximately $2,925,308.63. The disclosure for this sale can be found here. Insiders have sold 474,305 shares of company stock worth $33,776,113 in the last three months. 1.02% of the stock is currently owned by company insiders.
WARNING: “Colgate-Palmolive (CL) Receiving Somewhat Favorable News Coverage, Study Shows” was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://ledgergazette.com/2018/04/18/colgate-palmolive-cl-receiving-somewhat-favorable-news-coverage-study-shows.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.